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Background: Lyme borreliosis is the most prevalent tick-borne disease in Europe. Ixodes ricinus also carries other
pathogenic bacteria, but corresponding human diseases are rarely reported. Here, we compared the exposure to
Rickettsia helvetica and Rickettsia monacensis with that to Lyme borreliosis spirochetes. We assumed that their
exposure corresponds to their infection rate in questing I. ricinus.
Findings: Three Rickettsia species were detected in ticks with a total prevalence of 7.9%, of which the majority was
R. helvetica (78%) and R. monacensis (21%). From the same geographic area, skin biopsies of erythema migrans
patients were investigated for possible co-infections with Rickettsia spp.. Forty-seven out of 67 skin biopsies were
PCR positive for Borrelia burgdorferi s.l. and one sample was positive for R. monacensis. The Borrelia genospecies
from the R. monacensis positive patient was identified as Borrelia afzelii. The patient did not show any symptoms
associated with rickettsiosis.
Conclusions: Co-infections of I. ricinus with Rickettsia spp. and B. burgdorferi s.l. were as high as expected from the
individual prevalence of both pathogens. Co-infection rate in erythema migrans patients corresponded well with
tick infection rates. To our knowledge, this is the first reported co-infection of B. afzelii and R. monacensis.
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Erythema migrans (EM) is an early sign of Lyme disease,
which is caused by Borrelia burgdorferi sensu lato (s.l.)
spirochetes that are transmitted by ticks. A typical EM is
characterized by a bull’s-eye look with an expanding red
ring of active infection and inner clearing but other pre-
sentations of EM can be found as well [1]. As a first sign
of Lyme disease, it usually occurs at the site of the tick
bite and is associated with tick attachment duration of
more than 24 hours [2]. These premises make EM likely
sites of co-infection with other tick borne pathogens that
can be transmitted alongside B. burgdorferi s.l.. Rickettsia
spp. are, next to B. burgdorferi s.l., the most common
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distribution, and reproduction in any mediumvector of Lyme disease in Europe [3-6]. Some Rickettsia
species are well-established pathogens, while the pathogenic
potential of others has not been fully elucidated [7]. In-
vasion and potentially infecting tissue at the tick-bite
site is the first step tick-borne bacteria have to make in
order to cause disease. We investigated the co-infection
rates of ticks with these two pathogens and co-infections
in EM patients from Croatia. Part of the data from this
study has been published in a separate manuscript
dealing with focus on the genetic variation of Borrelia
genotypes [8].
For this purpose I. ricinus and EM skin biopsies were
tested with a B. burgdorferi s.l. duplex qPCR and a con-
ventional Rickettsia spp. PCR. DNA from vegetation
ticks and skin biopsies of EM patients was extracted and
tested for the presence of B. burgdorferi s.l. DNA [8].
Samples were tested for Rickettsia by conventional PCRntral Ltd. This is an open access article distributed under the terms of the
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sequenced and analyzed as described [4,9]. Positive and
negative controls were run with each tested batch. Posi-
tive control for the Rickettsia spp. PCR was a Rickettsia
africae positive patient sample [10]. Rickettsia africae is
not found in I. ricinus and can be differentiated from
rickettsial species in I. ricinus based on the 16S rRNA
gene.
Prevalence of Borrelia burgdorferi s.l. and Rickettsia spp. in
Croatian ticks and EM skin biopsies
Of 1432 I. ricinus tested for Borrelia 254 (17.7%) were
positive. Of 1273 I. ricinus tested for Rickettsia spp. 101
(7.9%) were positive [8]. Of these, 79 (78%) were identi-
fied as Rickettsia helvetica (100% homology to L36212),
21 (21%) as Rickettsia monacensis (100% homology to
[GenBank:DQ100164]) and one (1%) as Rickettsia raoultii
(100% homology to [GenBank:DQ365809]). Of 67 EM
skin samples 47 were B. burgdorferi s.l. positive (70%)
and one (1.5%) was Rickettsia sp. positive. The latter
sample was also positive for B. afzelii and the rickettsial
species was identified as R. monacensis (100% homology
to [GenBank:DQ365809]).
Case description
The R. monacensis positive patient was an eight-year-old
girl living in an urban environment. Six days prior to the
hospital visit the patients mother had noticed a red an-
nular rash on her daughter’s face. The rash expanded
throughout the following day and during the hospital
visit three EM lesions were noticed: around the left eye
(7×14 cm), at the anterior side of the right thigh (9×12 cm)
and on the right gluteus (11×17 cm). The skin biopsy was
taken from the gluteal EM. The patient complained about
itching but no other symptoms were reported or noted
during the visit. Neither the patient nor her mother recol-
lected any tick bites. After the diagnosis of Lyme borrelio-
sis presenting as multiple EMs following dissemination of
the infection, treatment with azithromycin (10 mg/kg) was
initiated. The antibiotic was administered twice on the
first treatment day and once daily until day five. The EMs
started to fade during the second treatment day and had
disappeared by day four. Serology later confirmed the
diagnosis of Lyme borreliosis but did not show a serocon-
version towards spotted fever group Rickettsia (data not
shown). Throughout the disease course, no symptoms in-
dicating a rickettsial co-infection were noticed. At check-
ups two weeks and two months after the initial visit, the
skin was clear and the patient was fully recovered.
Discussion
Derived from the Borrelia spp. and Rickettsia spp. infec-
tion rates in ticks of 17.7% and 7.9%, respectively, a theor-
etical co-infection rate of 1.4% was calculated (infectionrate of Borrelia spp. x infection rate of Rickettsia spp.).
The measured co-infection rate in the 1273 I. ricinus that
were tested for both bacteria was 1.4%. The theoretical
and actual co-infection rates in ticks were also calculated
for the combinations of the commonest Borrelia genospe-
cies (Borrelia garinii and B. afzelii) and Rickettsia species
(R. helvetica and R. monacensis) and theoretical and actual
co-infection rates for these combinations were also nearly
identical (data not shown). The detection of R. raoultii in
I. ricinus is surprising as this rickettsial species is asso-
ciated with Dermacentor spp. The R. raoultii preva-
lence in this study was only 0.08% and detection of this
DNA might be attributed to a recent infected blood
meal or a contamination of the tick sample with material
from Dermacentor marginatus ticks, which had been col-
lected simultaneously.
The measured co-infection rate of 1.4% in ticks indicates
that this percentage of EM patients has also been exposed
to Rickettsia spp.. In our study population of 67 EM cases,
this would translate to one patient (calculated: 0.94 pa-
tients). Indeed one skin sample was found Rickettsia spp.
positive. Although the study population is limited, this
indicates that transmission of Rickettsia spp. can occur
alongside of Borrelia spp. if the tick carries a double in-
fection. The current study population was too small to
draw a definite conclusion on the virulence and patho-
genicity differences of different rickettsial species found
in I. ricinus. However, as R. helvetica was almost four
times more common in ticks than R. monacensis, by
chance, R. helvetica would have been more likely to cause
co-infections in EM. Both, R. helvetica and R. monacensis,
are thought to be pathogenic but the full clinical picture
or the virulence are not known for either of these two spe-
cies [11,12]. In the current case, the patient did not seem
to suffer any symptoms associated with a Rickettsia spp.
infection. The erythematous lesions were attributed to the
B. burgdorferi s.l. infection and the patient recovered com-
pletely after a five-day course of antibiotics. Average incu-
bation time in children with multiple EM has been
reported to lie between 10 and 25 days [13,14]. The rick-
ettsial bacteria in the skin lesions have thus survived in
the skin for a similarly long period without being elimi-
nated by the patient’s immune system. Future case reports
and epidemiological studies would be necessary to
evaluate the clinical spectra and virulence of R. helvetica
and R. monacenis.Conclusions
In conclusion, the co-infection rates in EM patients with
Rickettsia spp. was as high as predicted by tick co-infection
rates. All symptoms of the patient with R. monacensis co-
infection can be explained by the B. afzelii infection and
the virulence of this rickettsial agent remains unclear.
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sidering co-infections when treating Lyme borreliosis.
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